Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.27 and traded as high as $0.79. Mesoblast shares last traded at $0.79, with a volume of 100 shares traded.
Mesoblast Trading Up 3.9 %
The company has a 50-day moving average of $0.41 and a 200 day moving average of $0.27.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to Calculate Stock Profit
- 3 Value Stocks You Can Buy Before They Become Big
- What Investors Need to Know About Upcoming IPOs
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
